- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Health
Tobias Egle leaves Merck's investment arm
Tobias Egle has left his role working for the tech and biotech venture fund M Ventures after three years at the CVC.
Apr 29, 2025CVC exits approach 2022 levels
Corporate-backed startups exits were at their highest level for over two years in Q1 2025, with large acquisitions spiking the total value.
Apr 14, 2025Origgi leaves Johnson & Johnson to lead immunotherapy startup
Origgi is joining Valo Therapeutics as CEO after four years at investment unit Johnson and Johnson Innovation,
Apr 11, 2025Corporates backed more startups in Q1, even stripping out the AI mega-deals
There were 1,215 corporate-backed startup funding rounds in Q1, the highest quarterly total for two years.
Apr 8, 2025Italian industrial group Angelini Industries hires Hodits to lead biotech investing
The hire is part of its goal to strengthen its presence in the biotech sector and expand its international investment platform.
Apr 7, 2025French pharma group Sanofi forms $275m China drugs fund
The launch of the fund follows Sanofi’s investment in a $1bn insulin production facility in Beijing, China.
Apr 4, 2025Don't believe the hype: impact funds aren't disappearing
The language may be changing but the opportunities and the returns are still there for impact investors.
Apr 4, 2025UK university spinout funding grows 38% year-on-year to $3.4bn - report
UK universities have also reduced their average equity stakes to new a new low.
Mar 26, 2025Kelly Shaw returns to consumer finance firm Synchrony's investment unit
Shaw was vice president of M&A at Synchrony Ventures before working in institutional VC.
Mar 25, 2025Corporate backing gives startups the edge when it comes to avoiding bankruptcy
Startups backed by corporate investors are less likely to go bust. This pattern holds true even in a tough investment climate.
Mar 20, 2025How corporate venture capital became a driving force in global innovation
Corporate investors have become pivotal players in VC markets around the globe, able to move markets. It’s now time to press our advantage.
Mar 18, 2025Hong Kong university plans $77m biotech fund
Anchor investor Shanghai Industrial Investment targets opportunities in biomedical sectors, including neurodegeneration and gene therapy.
Mar 14, 2025Featured Content
GCV Powerlist 2026Nominations for the 2026 GCV Powerlist are now open. Use this form to nominate yourself or someone else.GCV Powerlist 2026
Nominations for the 2026 GCV Powerlist are now open. Use this form to nominate yourself or someone else.
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
Corporate venture building reportData from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomesCorporate venture building report
Data from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomes
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation


